Anna Lam

2.2k citations
60 papers · 1.7k · 1 hit paper · h-index 25

Impact in

    • Cardiac Arrhythmias and Treatments
    • Atrial Fibrillation Management and Outcomes
    • Cardiac electrophysiology and arrhythmias
    • Cardiac pacing and defibrillation studies
    • Cardiovascular Disease and Adiposity
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Cardiac Arrhythmias and Treatments 35
    • Atrial Fibrillation Management and Outcomes 10
    • Cardiac pacing and defibrillation studies 10
    • Cardiac electrophysiology and arrhythmias 7
    • Takotsubo Cardiomyopathy and Associated Phenomena 2
    • ECG Monitoring and Analysis 2
    • Cardiovascular Disease and Adiposity 2
    • Chemotherapy-induced cardiotoxicity and mitigation 1

Anna Lam

56 papers receiving 1.7k citations

Anna Lam's Hit Papers

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 2022 · 249 citations
2490+1+2Years since publication50100150200

Peers

Anna Lam
Comparison fields: 5 of 46
  • Cardiology and Cardiovascular Medicine 1.5k
  • Internal Medicine 45
  • Genetics 94
  • Hematology 100
  • Anesthesiology and Pain Medicine 8
Replace Robert Schönbauer with:
Robert Schönbauer Austria
V. Vančura Czechia
Willem Dewilde Netherlands
Robért Petr Czechia
Michael Derndorfer Austria
Wim Anné Belgium
Franck Albert France
Jan van Es Netherlands
J. Stevenhagen Netherlands
Eiji Tamiya Japan
Anna Lam relative to Robert Schönbauer Austria Robert Schönbauer's profile →
Citations per field
00.5×2×3×4×
Robert Schönbauer · 1×
Citations per year

Countries citing papers authored by Anna Lam

Since Specialization
Citations

This map shows the geographic impact of Anna Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lam more than expected).

Fields of papers citing papers by Anna Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lam. The network helps show where Anna Lam may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Lam Line = papers co-authored together Anna Lam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Hit paper breakdown →
2022249
2 2018191
3 201979
4 201865
5 201860
6 201960
7 201855
8 202050
9 201845
10 201844
11 201943
12 201942
13 202041
14 201833
15 201933
16 201832
17 201931
18 201930
19 202230
20 202029

About Anna Lam

Anna Lam is a scholar working on Cardiology and Cardiovascular Medicine, Anesthesiology and Pain Medicine, Gender Studies, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 60 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (35 papers), Atrial Fibrillation Management and Outcomes (10 papers), Cardiac pacing and defibrillation studies (10 papers), Cardiac electrophysiology and arrhythmias (7 papers), Takotsubo Cardiomyopathy and Associated Phenomena (2 papers), ECG Monitoring and Analysis (2 papers), Cardiovascular Disease and Adiposity (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.5k citations), Internal Medicine (45 citations), Genetics (94 citations), Hematology (100 citations) and Anesthesiology and Pain Medicine (8 citations). Anna Lam has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include Nicolas Derval, Konstantinos George Vlachos, Τakeshi Kitamura, Masateru Takigawa, Antonio Frontera, Arnaud Denis, Mélèze Hocini, Ghassen Cheniti, Felix J. Bourier and Michel Haı̈ssaguerre. Their work appears in journals such as Journal of Cardiovascular Electrophysiology, Heart Rhythm, Circulation Arrhythmia and Electrophysiology, EP Europace and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact